These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 17351376

  • 21. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
    Murakami Y, Shimada T, Inoue S, Shimizu H, Ohta Y, Katoh H, Nakamura K, Ishibashi Y.
    Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
    [Abstract] [Full Text] [Related]

  • 22. Plasma aldosterone and its relationships with left ventricular mass in essential hypertensive patients with the metabolic syndrome.
    Mulè G, Nardi E, Cusimano P, Cottone S, Seddio G, Geraci C, Palermo A, Andronico G, Cerasola G.
    Am J Hypertens; 2008 Sep; 21(9):1055-61. PubMed ID: 18583983
    [Abstract] [Full Text] [Related]

  • 23. Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension.
    Soualmia H, Ayadi I, Omar S, Feki M, Drissa H, Mebazaa A, Kaabachi N.
    Clin Lab; 2009 Sep; 55(3-4):120-7. PubMed ID: 19462934
    [Abstract] [Full Text] [Related]

  • 24. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients.
    Sesti G, Sciacqua A, Scozzafava A, Vatrano M, Angotti E, Ruberto C, Santillo E, Parlato G, Perticone F.
    J Hypertens; 2007 Feb; 25(2):471-7. PubMed ID: 17211256
    [Abstract] [Full Text] [Related]

  • 25. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
    Ikeda N, Yasu T, Nishikimi T, Nakamura T, Kubo N, Kawakami M, Momomura S, Saito M.
    Regul Pept; 2007 Jun 07; 141(1-3):154-8. PubMed ID: 17292492
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    Chinali M, De Marco M, D'Addeo G, Benincasa M, Romano C, Galderisi M, de Simone G.
    J Hypertens; 2007 May 07; 25(5):1073-8. PubMed ID: 17414672
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension.
    Irzmanski R, Barylski M, Banach M, Piechota M, Kowalski J, Cierniewski C, Pawlicki L.
    Med Sci Monit; 2007 Oct 07; 13(10):CR449-56. PubMed ID: 17901852
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index.
    Sezen Y, Baş M, Demirbag R, Yildiz A, Celik H, Aksoy S.
    Clin Biochem; 2009 Oct 07; 42(15):1500-3. PubMed ID: 19615987
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
    Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Borch-Johnsen K, Ibsen H, Jørgensen T, Hildebrandt P.
    Hypertension; 2005 Oct 07; 46(4):660-6. PubMed ID: 16129819
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.